Want to join the conversation?
For 4Q15, $BBY expects a negative low-single digit revenue growth rate and a non-GAAP operating income rate decline of 25 to 45 BP. Due to the ongoing impacts of the Canadian brand consolidation and foreign currency fluctuations, $BBY expects its International segment revenue in 4Q15 to decline 30% YoverY.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)